SynAct Pharma (STO: SYNACT)

Last close As at 24/10/2025

SEK22.20

0.80 (3.74%)

Market capitalisation

SEK1,184m

SynAct Pharma is a clinical-stage biotechnology company focussed on the development of treatments to resolve, rather than inhibit, ongoing inflammatory processes in acute and chronic diseases.

Latest Insights

Healthcare | edison tv

SynAct Pharma – executive interview

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Jeppe Øvlesen

    CEO

  • Björn Westberg

    CFO

Thematics